Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.

Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ.

Gynecol Oncol. 2014 Jan;132(1):33-7. doi: 10.1016/j.ygyno.2013.11.033. Epub 2013 Dec 4.

PMID:
24316307
[PubMed - indexed for MEDLINE]
2.

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

Wheeler DT, Bristow RE, Kurman RJ.

Am J Surg Pathol. 2007 Jul;31(7):988-98.

PMID:
17592264
[PubMed - indexed for MEDLINE]
3.

[Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].

Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ.

Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):242-5. Chinese.

PMID:
16759458
[PubMed - indexed for MEDLINE]
4.

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S, Massey C, Ferguson SE.

Gynecol Oncol. 2014 May;133(2):229-33. doi: 10.1016/j.ygyno.2014.02.020. Epub 2014 Feb 19.

PMID:
24561246
[PubMed - indexed for MEDLINE]
5.

Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ.

Hum Pathol. 2010 Jan;41(1):26-32. doi: 10.1016/j.humpath.2009.06.012. Epub 2009 Sep 4.

PMID:
19733383
[PubMed - indexed for MEDLINE]
6.

Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.

Penner KR, Dorigo O, Aoyama C, Ostrzega N, Balzer BL, Rao J, Walsh CS, Cass I, Holschneider CH.

Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.

PMID:
22079678
[PubMed - indexed for MEDLINE]
7.

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.

Gunderson CC, Fader AN, Carson KA, Bristow RE.

Gynecol Oncol. 2012 May;125(2):477-82. doi: 10.1016/j.ygyno.2012.01.003. Epub 2012 Jan 11. Review.

PMID:
22245711
[PubMed - indexed for MEDLINE]
8.

Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.

Kudesia R, Singer T, Caputo TA, Holcomb KM, Kligman I, Rosenwaks Z, Gupta D.

Am J Obstet Gynecol. 2014 Mar;210(3):255.e1-4. doi: 10.1016/j.ajog.2013.11.001. Epub 2013 Nov 8.

PMID:
24211482
[PubMed - indexed for MEDLINE]
9.

Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.

Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, Kwon YS, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE, Kim TJ.

Int J Gynecol Cancer. 2009 Aug;19(6):1068-73. doi: 10.1111/IGC.0b013e3181aae1fb.

PMID:
19820370
[PubMed - indexed for MEDLINE]
10.

Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.

Minaguchi T, Nakagawa S, Takazawa Y, Nei T, Horie K, Fujiwara T, Osuga Y, Yasugi T, Kugu K, Yano T, Yoshikawa H, Taketani Y.

Cancer Lett. 2007 Apr 8;248(1):112-22. Epub 2006 Aug 21.

PMID:
16919866
[PubMed - indexed for MEDLINE]
11.

Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.

Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR.

Gynecol Oncol. 2005 Nov;99(2):472-6. Epub 2005 Aug 15.

PMID:
16099019
[PubMed - indexed for MEDLINE]
12.

Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.

Mentrikoski MJ, Shah AA, Hanley KZ, Atkins KA.

Am J Clin Pathol. 2012 Oct;138(4):524-34.

PMID:
23010707
[PubMed - indexed for MEDLINE]
Free Article
13.

Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.

Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W.

Gynecol Oncol. 2000 Nov;79(2):169-76.

PMID:
11063639
[PubMed - indexed for MEDLINE]
14.

Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature.

Baker J, Obermair A, Gebski V, Janda M.

Gynecol Oncol. 2012 Apr;125(1):263-70. doi: 10.1016/j.ygyno.2011.11.043. Epub 2011 Dec 3. Review.

PMID:
22196499
[PubMed - indexed for MEDLINE]
15.

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40.

Randall TC, Kurman RJ.

Obstet Gynecol. 1997 Sep;90(3):434-40.

PMID:
9277658
[PubMed - indexed for MEDLINE]
16.

Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.

Amezcua CA, Zheng W, Muderspach LI, Felix JC.

Gynecol Oncol. 1999 Apr;73(1):126-36.

PMID:
10094893
[PubMed - indexed for MEDLINE]
17.

[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].

Cao DY, Yu M, Yang JX, Shen K, Huang HF, Cheng NH, Sun ZY, Deng CY, Yu Q, He FF.

Zhonghua Fu Chan Ke Za Zhi. 2013 Jul;48(7):519-22. Chinese.

PMID:
24284224
[PubMed - indexed for MEDLINE]
18.

Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.

Yang YC, Wu CC, Chen CP, Chang CL, Wang KL.

Gynecol Oncol. 2005 Nov;99(2):287-93. Epub 2005 Jul 26.

PMID:
16051341
[PubMed - indexed for MEDLINE]
19.

Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.

Park JY, Lee SH, Seong SJ, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH.

Gynecol Oncol. 2013 Apr;129(1):7-11. doi: 10.1016/j.ygyno.2012.12.037. Epub 2012 Dec 30.

PMID:
23283299
[PubMed - indexed for MEDLINE]
20.

Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.

Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT.

Arch Gynecol Obstet. 2012 Feb;285(2):473-8. doi: 10.1007/s00404-011-1959-x. Epub 2011 Jun 25.

PMID:
21706284
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk